Abbott Laboratories Articles
Devgen sees good data in trials of oral TNF inhibitors
28 August 2006
SkyePharma and CTI submit reformulated zileuton to FDA
14 August 2006
Abbott's Humira gets FDA OK for AS
7 August 2006
Japan stock market week to July 31, 2006
7 August 2006
Japan stock market week to July 24, 2006
26 July 2006
Abbott's HBV blood test cleared by US FDA
24 July 2006
Abbott's 2nd qtr profit drops on Guidant buy
24 July 2006
Abbott Labs gains ABPI reinstatement
24 July 2006
Stock Commentary - Europe - week to July 10, 2006
17 July 2006
Takeda faces 57B yen tax bill regarding TAP
10 July 2006
Japan stock market week to July 3, 2006
10 July 2006
BI's Aptivus linked to intracranial bleeding
10 July 2006
Abbott's new Kaletra tablets approved by EC
10 July 2006
Japan stock market week to June 26, 2006
3 July 2006
Teva updates on generic Biaxin
3 July 2006
Humira in AS discussed at EULAR congress
3 July 2006
Abbott's Humira gets EU OK for AS
19 June 2006
Texas 'overcharged' by three drug firms
13 June 2006
Final appro for Lupin's cefdinir capsules
5 June 2006
US seniors call for ban on DTC ads
5 June 2006
Abbott Labs accused of "inflating prices" in USA
29 May 2006
CAT's profits hit L4.6M for six month to March
29 May 2006
Abbott to develop lung cancer test with ALSI
22 May 2006
Abbott's EU Zomaxx trial starts enrolling
22 May 2006
Japan stock market week to May 15, 2006
22 May 2006
Reductil probe in Australia after CV death
22 May 2006
Strong RA data for Abbott's Humira + MTX
15 May 2006
Abbott's new Kaltera tablet gets CHMP's OK
8 May 2006
UK pharma launches "CODE Day"
1 May 2006
Headlines 25 years ago this week....
1 May 2006
Japan stock market week to April 24, 2006
1 May 2006
John Thottathil joins New River as CSO
24 April 2006
Abbott gains EC approval for Guidant buy
17 April 2006
Headlines 25 years ago this week....
17 April 2006
Abbott donates $1M to encourage science
17 April 2006
Abbott files new formulation HIV drug in South Africa
10 April 2006
Richard Gonzalez promoted at Abbott Labs
27 March 2006
Axis Shield sees L1.9M operational profit in 2005
20 March 2006
15 US states to sue HHS over Medicare
13 March 2006
Japan stock market week to March 6, 2006
13 March 2006
Celera and Abbott Labs continue antigen accord
27 February 2006
Takeda 's income rises 14.4% in 1st 3 fiscal qtrs
20 February 2006
UPDATE: ABPI suspends Abbott Labs over hospitality, also raps GSK for breach of undertaking
20 February 2006
Abbott Laboratories suspended from ABPI
20 February 2006
Australian PBS changes could hit biotechs
13 February 2006
CAT 1st-qtr revenue reached L14M
13 February 2006
Timothy Walbert joins NeoPharm as VP commercial operations
6 February 2006
Japan's Taisho sees first nine month sales, earning slip but still ahead of forecast
6 February 2006
Japan stock market week to Jan 30, 2006
6 February 2006
Abbott/Orion's Simdax moves towards EU appro
6 February 2006
Pharma/biotech mergers and acquisitions during 2005
6 February 2006
Celera' sees 2nd-qtr 2006 net losses $17.3 M
6 February 2006
Abbott:13.4% 4th-qtr 2005 EPS growth, as expected
6 February 2006
SkyePharma chief quits under pressure
30 January 2006
Patents and innovation
9 January 2006
Japan stock market 3 weeks to Jan 2, 2006
9 January 2006
Nevada AG: Canada Rx imports "unworkable"
9 January 2006
Texas AG says Canadian Rx-buying is illegal
9 January 2006
Baxter launches sevoflurane in China
19 December 2005
Herceptin for early-stage use in Australia soon?
19 December 2005
Australian govt: no plans for PBS drug price rises
19 December 2005
FDA expands indiction of Abbott's Depakote ER
12 December 2005
Stock Commentary - New York week to Dec 5
12 December 2005
Danger to patients from weak US Rx system: CU
12 December 2005
25 years ago this week....
12 December 2005
Stock Commentary - New York week to Nov 28
5 December 2005
CAT's fiscal year results beat forecasts
5 December 2005
TAP licenses rights to Ilyang's ilaprazole
19 September 2005
FDA non-appro letters for Pfizer's Oporia and Abbott's Xinlay
19 September 2005
Cambridge Antibody Technology's 9-mth loss narrows; lower 3rd-qtr litigation costs
19 September 2005
Abbott debuts Precision Xtra in Europe
19 September 2005
BioVisioN signs research deal with Abbott
19 September 2005
EC approves Medtronic's Endeavor drug-eluting stent
12 September 2005
Stock Commentary - Tokyo week to Sept 5
12 September 2005
US FDA advisers urge appro of B-MS' Orencia
12 September 2005
Japan stock market week to September 5
12 September 2005
Abbott granted distribution rights to Axis-Shield's Afinion
5 September 2005
MedImmune to regain Synagis promotion rights from Abbott
5 September 2005
TAP's TAK-390MR enters Ph III
5 September 2005
Abbott's blood glucose monitor cleared in USA
22 August 2005
US feds urged to probe Wall St R&D "leaks"
15 August 2005
Takeda's 1st-qtr stronger-than-expected due to volume growth
15 August 2005
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
